当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析 - 现金流量表

丸美生物

(603983)

  

流通市值:99.61亿  总市值:99.61亿
流通股本:4.01亿   总股本:4.01亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,922,166,113.162,507,857,434.481,795,275,069.67940,368,885.05
  收到的税费返还-50,749.8851,130.7420,438.86
  收到其他与经营活动有关的现金76,313,507.1550,292,275.8844,247,489.713,667,503.49
  经营活动现金流入小计3,998,479,620.312,558,200,460.241,839,573,690.11954,056,827.4
  购买商品、接受劳务支付的现金1,017,504,988.33821,382,359.36596,515,187.7320,428,057.22
  支付给职工以及为职工支付的现金266,436,208.27195,852,784.32131,348,731.7569,571,611.7
  支付的各项税费267,994,938.88195,300,610.67147,798,515.6666,211,607.23
  支付其他与经营活动有关的现金2,172,667,082.511,186,791,466.36784,381,420.61525,433,112.52
  经营活动现金流出小计3,724,603,217.992,399,327,220.711,660,043,855.72981,644,388.67
  经营活动产生的现金流量净额273,876,402.32158,873,239.53179,529,834.39-27,587,561.27
二、投资活动产生的现金流量:
  收回投资收到的现金140,000,000105,000,000105,000,00045,739,075.35
  取得投资收益收到的现金3,771,504.652,884,389.432,862,510.371,063,408.68
  处置固定资产、无形资产和其他长期资产收回的现金净额24,346.17---
  处置子公司及其他营业单位收到的现金净额118,918.4---
  收到的其他与投资活动有关的现金49,527,54049,467,84049,467,84049,527,540
  投资活动现金流入小计193,442,309.22157,352,229.43157,330,350.3796,330,024.03
  购建固定资产、无形资产和其他长期资产支付的现金205,247,767.2177,169,465.9120,365,414.7869,236,457.12
  投资支付的现金302,130,000147,130,000115,000,00055,000,000
  投资活动现金流出小计507,377,767.2324,299,465.9235,365,414.78124,236,457.12
  投资活动产生的现金流量净额-313,935,457.98-166,947,236.47-78,035,064.41-27,906,433.09
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金1,437,822,791.35440,309,091.9415,388,536.34-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计1,437,822,791.35440,309,091.9415,388,536.34-
  偿还债务支付的现金150,000,000150,000,000150,000,000150,000,000
  分配股利、利润或偿付利息支付的现金301,341,400.93200,672,175.8200,666,388.19135,416.67
  其中:子公司支付给少数股东的股利、利润455,984.26---
  支付其他与筹资活动有关的现金1,584,214,907.56472,434,628.5421,884,336.311,497,919.56
  筹资活动现金流出小计2,035,556,308.49823,106,804.3772,550,724.5151,633,336.23
  筹资活动产生的现金流量净额-597,733,517.14-382,797,712.4-357,162,188.16-151,633,336.23
四、汇率变动对现金及现金等价物的影响-6,647.4925,235.78124,244.9820,332.55
五、现金及现金等价物净增加额-637,799,220.29-390,846,473.56-255,543,173.2-207,106,998.04
  加:期初现金及现金等价物余额1,579,060,009.941,579,060,009.941,579,060,009.941,579,060,009.94
  期末现金及现金等价物余额941,260,789.651,188,213,536.381,323,516,836.741,371,953,011.9
补充资料:
  净利润246,742,825.83-174,712,447.04-
  资产减值准备3,287,597.39-1,349,645.31-
  固定资产和投资性房地产折旧42,043,888.55-15,816,105.8-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧42,043,888.55-15,816,105.8-
  无形资产摊销19,762,865.84-1,866,733.84-
  长期待摊费用摊销973,479.91-6,412,402.73-
  处置固定资产、无形资产和其他长期资产的损失-377,398.06--377,398.06-
  固定资产报废损失259,847.08-39,562.75-
  公允价值变动损失-432,554.85--587,598.74-
  财务费用3,808,356.01-2,656,560.66-
  投资损失-27,553,438.99--2,783,249.38-
  递延所得税-16,995,221.31-4,347,474.62-
  其中:递延所得税资产减少-18,982,813.59-5,872,785.95-
    递延所得税负债增加1,987,592.28--1,525,311.33-
  存货的减少-16,978,963.04--22,795,755.2-
  经营性应收项目的减少54,365,901.07-21,324,624.09-
  经营性应付项目的增加-36,548,056.92--22,390,834.6-
  其他---428,994.71-
  现金的期末余额941,260,789.65-1,323,516,836.74-
  减:现金的期初余额1,579,060,009.94-1,579,060,009.94-
  现金及现金等价物的净增加额-637,799,220.29--255,543,173.2-
公告日期2026-04-012025-10-312025-08-232025-04-26
审计意见(境内)标准无保留意见
TOP↑